• <s id="i2ew8"></s>
    <li id="i2ew8"><xmp id="i2ew8">
  • Company News

    • Snibe received CE List A Certificate for HBV Detection

      Shenzhen, China, 26 May 2022-- Snibe has received the CE List A Certificate for 5 MAGLUMI? CLIA immunoassays of Hepatitis B virus (HBV) detection, covering Anti-HBc IgM, Anti-HBs, HBeAg, Anti-HBe, and anti-HBC. Up to now, 6 CLIA immunoassays for HBV detection have all obtained CE List A Certificate, besides the MAGLUMI? HBsAg (CLIA) Assay.  

    • Snibe Gets CE Mark for COVID-19 Antigen Self-Testing

      Recently, Snibe receives the CE mark for its RapisafeTM SARS-CoV-2 Ag test (Colloidal Gold), which further confirmed that the quality of our Self-Testing kits is in line with international standards.

    • Snibe announced a global strategic cooperation with Thermo Fisher Scientific

      From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.

    • Snibe Collaborates with PKU SBMS to Launch Multicenter Study of HCC

      Aiming to further explore the clinical application of serological indicators in early screening and diagnosis of HCC, the School of Basic Medical Sciences Peking University (SBMS, PKU) held an online meeting on June 25, 2022, to officially announce the launch of the project: Multicenter Study in Evaluating the Combination of Multiple Indicators in HCC Screening. Snibe is the exclusive industry supporter.

    • Snibe received CE certificate (List A) for MAGLUMI HBsAg (CLIA) Assay

      Snibe received the CE certificate (List A) for MAGLUMI? HBsAg (CLIA) assay On March 11, 2022. It further proves the high reliability of the quality and performance of Snibe products, as well as a verification of Snibe’s leading position in the field of chemiluminescence.  

    more >>

    • Snibe received CE List A Certificate for HBV Detection

      Shenzhen, China, 26 May 2022-- Snibe has received the CE List A Certificate for 5 MAGLUMI? CLIA immunoassays of Hepatitis B virus (HBV) detection, covering Anti-HBc IgM, Anti-HBs, HBeAg, Anti-HBe, and anti-HBC. Up to now, 6 CLIA immunoassays for HBV detection have all obtained CE List A Certificate, besides the MAGLUMI? HBsAg (CLIA) Assay.  More

    • Snibe Gets CE Mark for COVID-19 Antigen Self-Testing

      Recently, Snibe receives the CE mark for its RapisafeTM SARS-CoV-2 Ag test (Colloidal Gold), which further confirmed that the quality of our Self-Testing kits is in line with international standards.More

    • Snibe announced a global strategic cooperation with Thermo Fisher Scientific

      From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.More

    • Snibe Collaborates with PKU SBMS to Launch Multicenter Study of HCC

      Aiming to further explore the clinical application of serological indicators in early screening and diagnosis of HCC, the School of Basic Medical Sciences Peking University (SBMS, PKU) held an online meeting on June 25, 2022, to officially announce the launch of the project: Multicenter Study in Evaluating the Combination of Multiple Indicators in HCC Screening. Snibe is the exclusive industry supporter.More

    • Snibe received CE certificate (List A) for MAGLUMI HBsAg (CLIA) Assay

      Snibe received the CE certificate (List A) for MAGLUMI? HBsAg (CLIA) assay On March 11, 2022. It further proves the high reliability of the quality and performance of Snibe products, as well as a verification of Snibe’s leading position in the field of chemiluminescence.  More

    Marketing Activity

    • Snibe Shines at the WorldLab 2022 in Seoul

      WorldLab Seoul 2022, the 24th International Congress of Clinical Chemistry and Laboratory Medicine is held at Coex, Seoul, Korea on 26-30 June 2022, which presents and discusses the latest advances in clinical laboratory diagnosis together with global attendees.

    • Snibe Shows Great Charms at EuroMedlab 2022 in Munich

      EuroMedlab Munich 2022, the largest exhibition in the field of Clinical Chemistry and Laboratory Medicine in Europe, which attracted more than 2000 participants, was held in ICM International Congress Center from April 10 to 14, 2022.

    • Snibe Showcases Total Lab Automation at MEDLAB 2020

      From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market.

    • Snibe Shines at Medica 2019

      Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st.

    • Snibe Shows Great Charms at 71th AACC

      Snibe brings the latest innovation MAGLUMI X8 to 71st AACC Annual Scientific Meeting & Clinical Lab Expo, with booth No. 1317 in California United States, one of the largest and most influential medical exhibitions across the world, attracting more than 21,000 visitors, and 800 exhibitors dedicated to sharing the most advanced technology available in the IVD, and medical laboratory market.

    more >>

    • Snibe Shines at the WorldLab 2022 in Seoul

      WorldLab Seoul 2022, the 24th International Congress of Clinical Chemistry and Laboratory Medicine is held at Coex, Seoul, Korea on 26-30 June 2022, which presents and discusses the latest advances in clinical laboratory diagnosis together with global attendees.More

    • Snibe Shows Great Charms at EuroMedlab 2022 in Munich

      EuroMedlab Munich 2022, the largest exhibition in the field of Clinical Chemistry and Laboratory Medicine in Europe, which attracted more than 2000 participants, was held in ICM International Congress Center from April 10 to 14, 2022.More

    • Snibe Showcases Total Lab Automation at MEDLAB 2020

      From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market.More

    • Snibe Shines at Medica 2019

      Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st.More

    • Snibe Shows Great Charms at 71th AACC

      Snibe brings the latest innovation MAGLUMI X8 to 71st AACC Annual Scientific Meeting & Clinical Lab Expo, with booth No. 1317 in California United States, one of the largest and most influential medical exhibitions across the world, attracting more than 21,000 visitors, and 800 exhibitors dedicated to sharing the most advanced technology available in the IVD, and medical laboratory market.More

    Video Center

    SATLARS-TCA
    SATLARS-TCA, a total laboratory automation solutions combined with high throughput, flexibility and scalability, has been grandly launched by Snibe and Thermo Fisher Scientific. SATLARS-TCA connected with the world's fastest CLIA analyzer MAGLUMI X8 possesses the high-throughput sample pre- treatment capability and large storage volume post-analytical module, which makes it a nice automated solution for global laboratories.

    More

    More

    Overseas Exhibition

    Item Conference Title Conference Name Date/Location Appointment
    1 AACC Middle East 2022.11.05-06/Dubai, UAE Attend
    2 Medica 2022.11.14-17/Germany Attend
    3 Medlab Middle East 2023.02.06-09/Dubai Attend
    4 Euromedlab 2023.05.21-25/Roma, Italy Attend
    5 AACC 2023.07.23-27/Anaheim, USA Attend
    Make an appointment
    • * Appointment Time:
    • * Name:
    • * Country:
    • Position:
    • Company/Hospital:
    • * Email:
    • Phone:

    Your Other Intention

    成年网站免费视频黄a站无码,精品中文字幕在线AⅤ,最新无码在线,久久思思热国产视频